Los Angeles Biotechnology Network
GOOGLE Advertise With Biotech Networks
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Advertise
  • BN Connect
    • About Biotech Networks Connect
    • BN Connect
  • Subscribe
  • Contact
News Ticker
  • [ October 9, 2026 ] Diabetes Sales Associate Los Angeles Biotech Jobs
  • [ October 9, 2026 ] Strongpoint Partners Platform Grows with Addition of Hilde Minkel & Associates Los Angeles Biotech News
  • [ October 9, 2026 ] HICE and Gabeo.ai Join Forces to Advance Transparency in Healthcare Risk Contracts Los Angeles Biotech News
  • [ October 8, 2026 ] SELENA GOMEZ ANNOUNCES LEON BRIDGES AND BELLA KAY AS ENTERTAINMENT FOR THE FOURTH ANNUAL RARE IMPACT FUND BENEFIT Los Angeles Biotech News
  • [ October 8, 2026 ] Lear Capital’s New “Outside the Dollar” Podcast Reaches Top 15 on Apple Investing Chart Los Angeles Biotech News
HomeLos Angeles Biotech NewsOpinion: Vaccine equity: If we build it, will they come?

Opinion: Vaccine equity: If we build it, will they come?

February 24, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Opinion: Vaccine equity: If we build it, will they come?

It’s important to work with communities to improve outreach, vaccine education, and identify and reduce barriers to vaccine access in the local context.

Previous

For UCLA-based startup, new muscular dystrophy treatment is a personal mission

Next

New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients

Follow/Subscribe

GOOGLE Advertise With Biotech Networks
POST A JOB
Advertise With Biotech Networks

Copyright © 2026 Biotech Networks, LLC

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox